Pancreatic Cancer Research

ResearcherGuangdong Academy of Medical SciencesActive in the last 2 years

Tingting Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6113-1624; OpenAlex author ID A5100416475. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2025: 2 papers

Papers 2

  1. Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation. Co-author DOI 10.1038/s41419-025-07431-4↗
  2. Cancer-associated fibroblast-derived circKLHL24 drives perineural invasion in pancreatic cancer via dual regulation of the sec31a-CXCL12 axis. Co-author DOI 10.1186/s13046-025-03489-2↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tianhao Huang · 2 shared papers, 2025 · strength 0.46
  2. Shangyou Zheng · 2 shared papers, 2025 · strength 0.46
  3. Rufu Chen · 2 shared papers, 2025 · strength 0.46
  4. Rihua He · 2 shared papers, 2025 · strength 0.46
  5. Zhiqiang Fu · 1 shared paper, 2025 · strength 0.24
  6. Chonghui Hu · 1 shared paper, 2025 · strength 0.24
  7. Shizong Li · 1 shared paper, 2025 · strength 0.22
  8. Guolin Li · 1 shared paper, 2025 · strength 0.22
  9. Chengyuan Hu · 1 shared paper, 2025 · strength 0.22
  10. Huimou Chen · 1 shared paper, 2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.